scholarly journals Exploring the Rescue Strategy for Cardiac Arrest in Makeshift (FangCang) Hospital Workers during the Pneumonia Outbreak Associated with COVID-19

Author(s):  
Ke FENG ◽  
Bin MEI ◽  
Zhongwei CHEN ◽  
Xufeng FU

Background: Beginning in Dec 2019, a novel coronavirus, designated SARS-CoV-2, has caused an international outbreak of respiratory illness termed COVID-19. The workers in the FangCang hospital have to work for more than 8 h and the work is high strength. Furthermore, to protect health and prevent serious cross-infection, they need to wear isolation equipment when working in FangCang hospital. These characteristics increase the risk of cardiac arrest (CA), which seriously endangers the lives of workers. Methods: We participated in the rescue of the patient and workers at first-line in FangCang hospital, and summarized the rescue strategies for workers rescuing. Results: Workers with CA were rescued in time according our guideline and showed zero dead in FangCang hospital. Conclusion: This study establishes the strategy for the CA of workers including the establishment of an in-FangCang resuscitation team, the establishment of a dedicated rescue room, and the formulation of rescue measures and procedures for CA of workers in the FangCang hospital. Therefore, we aimed to provide a strategy for the rescue of workers with CA in the FangCang hospital and share the success in rescuing with the world.

2021 ◽  
Vol 10 (4) ◽  
pp. 880
Author(s):  
Fery AM Mendrofa ◽  
Umi Hani ◽  
Yuni Nurhidayat

A pandemic of a novel coronavirus-infected disease is currently ongoing in the world. Most patients have to be isolated due to the treatments. This study aimed to make sense of how patients with coronavirus-infected disease understand and experience infectious isolation. The research used a qualitative design with a phenomenological approach. Data collection was conducted with in-depth interviews of nine patients with coronavirus disease-2019 (COVID-19) confirmed who had been in the isolation room. The analysis was conducted on interview transcripts by organizing keywords found into categories, sub-themes, and themes based on Colaizzi's approach. The results indicated that the participants experienced fright due to the isolation and attempted to integrate their isolation experiences. Isolation highlighted a sense of threat posed by cross-infection, a threat that participants experienced as originating from others and from themselves to others. Participants described feeling changes experienced after several days of treatment. Participants reported various symptoms of the disease and received careful care while in isolation. They still communicate with family. Isolated patients are able to deal with the treatment by improving their coping strategies. Participants reported the most support from their families, even from a distance. Future research could explore experiences of isolation from family and staff perspectives and identify the psychological aspect in caring for the COVID-19 patients.


2020 ◽  
Vol 81 (2) ◽  
pp. 1-2
Author(s):  
Maxime T Rigaudy ◽  
Feras Tomalieh ◽  
Sanya Caratella

The composition of the cardiac arrest team varies widely both throughout the UK and the world. There are no agreed standards regarding the composition of the resuscitation team, and variety in teams is often dictated by availability of staff and financial constraints. This article discusses the evidence for and against the inclusion of critical care doctors on the cardiac arrest call team.


2021 ◽  
Author(s):  
Richmond Sam Quarm ◽  
Rosemond Sam-Quarm ◽  
Richmond Sam-Quarm

The novel, dreaded, disruptive, and disastrous Covid-19 pandemic took the world by storm in January, 2020. The Covid-19 pandemic in Ghana is part of the worldwide coronavirus disease caused by “severe acute respiratory syndrome (SARS-CoV-2)”. On 12th January, 2020 the World Health Organisation (WHO) confirmed that the novel coronavirus was the cause of a respiratory illness that affected a cluster of people in Wuhan City, Hubei Province, China. This was reported to the WHO on 31st December, 2019. On 11th March, 2020, WHO declared the novel Covid-19 a global pandemic (Graphic Online, 2020a). It is worthy to note how the Government of Ghana, political parties, citizens, scientists and academia, corporate entities, faith based organisations, traditional rulers, have offered varied forms of interventions to combat the scourge. The Theoretical Framework of this research was underpinned by the Theory of Epidemics, the Agency Theory, the Rational Choice Theory, and the Stakeholder Theory. We conducted a cross-sectional research through non-probability and purposive sampling with 250 respondents. We also employed face-to-face interviews, structured closed-ended and open-ended Questionnaires (Braun and Clarke, 2012; Denzin, 2017), which were administered online through email application via Google Forms. One of our major findings was that with the approval of Pfizer/BioNTech Covid-19 vaccine by the UK’s MHRA on 1st December, 2020 (Graphic Online, 2020b); and subsequently by the US FDA a week later on 8th December, 2020 (Graphic Online, 2020c), all governments around the globe in general, but Africa in particular, must make conscious efforts backed by adequate budgetary allocations to secure maximum quantities of the vaccines for their vulnerable teeming population.


2021 ◽  
Author(s):  
Richmond Sam Quarm ◽  
Rosemond Sam-Quarm ◽  
Richmond Sam-Quarm

The novel, dreaded, disruptive, and disastrous Covid-19 pandemic took the world by storm in January, 2020. The Covid-19 pandemic in Ghana is part of the worldwide coronavirus disease caused by “severe acute respiratory syndrome (SARS-CoV-2)”. On 12th January, 2020 the World Health Organisation (WHO) confirmed that the novel coronavirus was the cause of a respiratory illness that affected a cluster of people in Wuhan City, Hubei Province, China. This was reported to the WHO on 31st December, 2019. On 11th March, 2020, WHO declared the novel Covid-19 a global pandemic (Graphic Online, 2020a). It is worthy to note how the Government of Ghana, political parties, citizens, scientists and academia, corporate entities, faith based organisations, traditional rulers, have offered varied forms of interventions to combat the scourge. The Theoretical Framework of this research was underpinned by the Theory of Epidemics, the Agency Theory, the Rational Choice Theory, and the Stakeholder Theory. We conducted a cross-sectional research through non-probability and purposive sampling with 250 respondents. We also employed face-to-face interviews, structured closed-ended and open-ended Questionnaires (Braun and Clarke, 2012; Denzin, 2017), which were administered online through email application via Google Forms. One of our major findings was that with the approval of Pfizer/BioNTech Covid-19 vaccine by the UK’s MHRA on 1st December, 2020 (Graphic Online, 2020b); and subsequently by the US FDA a week later on 8th December, 2020 (Graphic Online, 2020c), all governments around the globe in general, but Africa in particular, must make conscious efforts backed by adequate budgetary allocations to secure maximum quantities of the vaccines for their vulnerable teeming population.


2020 ◽  
Vol 04 (01) ◽  
pp. 20-24
Author(s):  
Prachee Sathe ◽  
Vijay Sundar Singh

AbstractIn late 2019, China reported cases of respiratory illness in humans, which involved a novel Coronavirus SARS-CoV-2 (also known as 2019-nCoV). The World Health Organization (WHO) termed the disease COVID-19 (i.e., Coronavirus disease 2019). Most of the morbidity and mortality from COVID-19 is largely due to acute viral pneumonitis that leads to acute respiratory distress syndrome (ARDS). This article will discuss the clinical features of the multiorgan involvement in COVID-19 as well as the management of patients who become critically ill due to COVID-19.


2021 ◽  
Vol 11 (1) ◽  
pp. 01-18
Author(s):  
Shweta Jain ◽  
◽  
Pankaj Kumar Jain ◽  
Ramakant Yadav ◽  
Surendra Kumar Jain ◽  
...  

The sudden outbreak of 2019 novel coronavirus (2019-nCoV) caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) originated from Wuhan, China. SARS-CoV-2 causes severe respiratory illness and becomes a major threat for humanity. Recently the entire scientist, researchers and physicians all over the countries focused to find the treatment of this pandemic disease. Numerous drugs and or vaccines have been trialed for prevention and treatment against 2019-nCoV but no therapy has been shown effective to date. Currently, numerous vaccines are under clinical investigation and mRNA-1273 vaccine (LNP- encapsulated mRNA vaccine encoding S protein) from Moderna is ahead. Although chloroquine, hydroxychloroquine, remdesivir and many other drugs had recommended against SARS-CoV-2, but still they are not the guarantee treatment of COVID-19. Recently, India, America, Russia and China introduced vaccines against COVID-19 in the market, however assurance of their 100% effectiveness are doubtful. The speed of daily new cases threatens the world and urges the scientist to crack this pandemic condition. KEYWORDS: 2019-nCoV; Chloroquine; COVID-19; Moderna; Respiratory disease; Remdesivir.


2021 ◽  
Vol 4 (1) ◽  
Author(s):  
Richmond Sam Quarm ◽  
◽  
Rosemond Sam-Quarm ◽  
Richmond Sam-Quarm ◽  
◽  
...  

The novel, dreaded, disruptive, and disastrous Covid-19 pandemic took the world by storm in January, 2020. The Covid-19 pandemic in Ghana is part of the worldwide coronavirus disease caused by “severe acute respiratory syndrome (SARS-CoV-2)”. On 12th January, 2020 the World Health Organisation (WHO) confirmed that the novel coronavirus was the cause of a respiratory illness that affected a cluster of people in Wuhan City, Hubei Province, China. This was reported to the WHO on 31st December, 2019. On 11th March, 2020, WHO declared the novel Covid-19 a global pandemic (Graphic Online, 2020a). It is worthy to note how the Government of Ghana, political parties, citizens, scientists and academia, corporate entities, faith based organisations, traditional rulers, have offered varied forms of interventions to combat the scourge. The Theoretical Framework of this research was underpinned by the Theory of Epidemics, the Agency Theory, the Rational Choice Theory, and the Stakeholder Theory. We conducted a cross-sectional research through non-probability and purposive sampling with 250 respondents. We also employed face-to-face interviews, structured closed-ended and open-ended Questionnaires (Braun and Clarke, 2012; Denzin, 2017), which were administered online through email application via Google Forms. One of our major findings was that with the approval of Pfizer/BioNTech Covid-19 vaccine by the UK’s MHRA on 1st December, 2020 (Graphic Online, 2020b); and subsequently by the US FDA a week later on 8th December, 2020 (Graphic Online, 2020c), all governments around the globe in general, but Africa in particular, must make conscious efforts backed by adequate budgetary allocations to secure maximum quantities of the vaccines for their vulnerable teeming population.


Pathogens ◽  
2020 ◽  
Vol 9 (3) ◽  
pp. 186 ◽  
Author(s):  
Hossam M. Ashour ◽  
Walid F. Elkhatib ◽  
Md. Masudur Rahman ◽  
Hatem A. Elshabrawy

Coronaviruses (CoVs) are RNA viruses that have become a major public health concern since the Severe Acute Respiratory Syndrome-CoV (SARS-CoV) outbreak in 2002. The continuous evolution of coronaviruses was further highlighted with the emergence of the Middle East Respiratory Syndrome-CoV (MERS-CoV) outbreak in 2012. Currently, the world is concerned about the 2019 novel CoV (SARS-CoV-2) that was initially identified in the city of Wuhan, China in December 2019. Patients presented with severe viral pneumonia and respiratory illness. The number of cases has been mounting since then. As of late February 2020, tens of thousands of cases and several thousand deaths have been reported in China alone, in addition to thousands of cases in other countries. Although the fatality rate of SARS-CoV-2 is currently lower than SARS-CoV, the virus seems to be highly contagious based on the number of infected cases to date. In this review, we discuss structure, genome organization, entry of CoVs into target cells, and provide insights into past and present outbreaks. The future of human CoV outbreaks will not only depend on how the viruses will evolve, but will also depend on how we develop efficient prevention and treatment strategies to deal with this continuous threat.


2020 ◽  
Vol 7 (4) ◽  
pp. 16-31
Author(s):  
Mohammad Abul Hossain

On 11 February 2020, the WHO declared the Coronavirus disease 2019 (COVID-19) as a new pandemic defined as the illness caused by a novel coronavirus now called severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) which was first identified amid an outbreak of respiratory illness cases in Wuhan City, Hubei Province, China.  It has not been previously identified in humans but WHO mentioned the virus, SARS-CoV-2 is transmitted from human to human by hand. The COVID-19 has been spreading rapidly across the world, affecting more than 185 countries. Up to 11 May 2020, over four million people are infected and over one fourth of million individuals around the world have died from the COVID-19. Till now, there is no approved medicine to prevent COVID-19 infection. WHO said, it is one year away to receive COVID-19 vaccine. The above panic situation and global pandemic insists me to consider, it is the Third World War of Divine Creator, Allah by Bio-weapon due to Human’s recent activity against the Creator such as modification of the Holy Qur’an, insulting the Prophet Muhammad (peace be upon him), etc. This paper presents the evidence of the involvement of Divine Creator in this pandemic, and the transmission of COVID-19 by human hand is simulated with the Divine Creator’s Code “19”. Based on the simulation, a probable treatment process is proposed to immediate relief of mankind from COVID-19. Again, evaluated by Divine Creator’s Code 19, it is suggested that the vaccine mRNA-1273, developed at the biotechnology company Moderna in Massachusetts, could be applicable (2-dose schedule at Day 57) to prevent infection with SARS-CoV-2 causes the disease COVID-19 but it is taking time for testing of safe and effectiveness which is going on in the National Institute of Allergy and Infectious Diseases Research Center in the United States of America.


Author(s):  
Nilmini Wickramasinghe ◽  
Juergen Seitz

The novel coronavirus (SARS-CoV-2) first identified in Wuhan, China in late December 2019 was identified as a pandemic by the World Health Organization (WHO) in March 2020 and has caused tremendous disruption to economies around the world and significant loss of life and serious illness. The current outbreak which has been thought to have originated in an animal wet market in late 2019, being transferred from the horse shoe bat to the pangolin, is well adapted to human cell receptors. This enables it to easily infect people with an R0 of approximately 2.2 causing a respiratory illness (COVID-19) which can develop into pneumonia in moderate to severe cases. Older adults and people with underlying medical conditions are at higher risk. The following outlines a responsible digital health solution.


Sign in / Sign up

Export Citation Format

Share Document